-

Novanta to Present at the Jefferies Global Healthcare Conference on Wednesday, November 18, 2026

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and John Lesica, Chief Operating Officer of Medical Solutions, are scheduled to present at the Jefferies Global Healthcare Conference on Wednesday, November 18, 2026, in London.

About Novanta

Novanta is a leading global supplier of core technology solutions that give medical, life science, and advanced industrial original equipment manufacturers a competitive advantage. We combine deep proprietary expertise and competencies in precision medicine, precision manufacturing, robotics and automation, and advanced surgical technologies with a proven ability to solve complex technical challenges. This enables Novanta to engineer proprietary technology solutions that deliver extreme precision and performance, tailored to our customers' demanding applications. The driving force behind our growth is the team of innovative professionals who share a commitment to innovation, the Novanta Growth System, and our customers’ success. Novanta’s common shares are quoted on Nasdaq under the ticker symbol “NOVT.”

More information about Novanta is available on the Company’s website at www.novanta.com. For additional information, please contact Novanta Inc. Investor Relations.

Contacts

Novanta Inc.
Investor Relations Contact:
(781) 266-5137
InvestorRelations@novanta.com

Novanta Inc.

NASDAQ:NOVT

Release Versions

Contacts

Novanta Inc.
Investor Relations Contact:
(781) 266-5137
InvestorRelations@novanta.com

More News From Novanta Inc.

Novanta Announces Financial Results for the Third Quarter 2026

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the third quarter 2026. Financial Highlights Three Months Ended   (In millions, except per share amounts) October 2,     September 26,     2026     2025   GAAP           Revenue $ 305.0     $ 247.8   Operating Income $ 13.9     $ 21.8   Net Income $ 2.0     $ 10.7   Diluted EPS $ 0.05    ...

Novanta to Present at the Baird 2026 Global Industrial Conference on Wednesday, November 11, 2026

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, and John Lesica, Chief Operating Officer of Medical Solutions, are scheduled to present at the Baird 2026 Global Industrial Conference on Wednesday, November 11, 2026, in Chicago, Illinois. About Novanta Novanta is a leading global supplier of core technology solutions that giv...

Novanta Inc. Announces Schedule of Third Quarter 2026 Earnings Release and Conference Call

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2026 results after the close of U.S. financial markets on Monday, November 9, 2026. The Company will host a conference call on Tuesday, November 10, 2026 at 8:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conf...
Back to Newsroom